These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33776470)

  • 21. GEN-O-MA project: an Italian network studying clinical course and pathogenic pathways of moyamoya disease-study protocol and preliminary results.
    Bersano A; Bedini G; Nava S; Acerbi F; Sebastiano DR; Binelli S; Franceschetti S; Faragò G; Grisoli M; Gioppo A; Ferroli P; Bruzzone MG; Riva D; Ciceri E; Pantaleoni C; Saletti V; Esposito S; Nardocci N; Zibordi F; Caputi L; Marzoli SB; Zedde ML; Pavanello M; Raso A; Capra V; Pantoni L; Sarti C; Pezzini A; Caria F; Dell' Acqua ML; Zini A; Baracchini C; Farina F; Sanguigni S; De Lodovici ML; Bono G; Capone F; Di Lazzaro V; Lanfranconi S; Toscano M; Di Piero V; Sacco S; Carolei A; Toni D; Paciaroni M; Caso V; Perrone P; Calloni MV; Romani A; Cenzato M; Fratianni A; Ciusani E; Prontera P; Lasserve ET; Blecharz K; Vajkoczy P; Parati EA;
    Neurol Sci; 2019 Mar; 40(3):561-570. PubMed ID: 30604336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult Moyamoya Disease and Moyamoya Syndrome: What Is New?
    Uchiyama S; Fujimura M
    Cerebrovasc Dis Extra; 2024; 14(1):86-94. PubMed ID: 39043157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathology of Moyamoya angiopathy in a European patient.
    Kraemer M; Keyvani K; Berlit P; Diesner F; Marquardt M
    J Neurol; 2019 Sep; 266(9):2258-2262. PubMed ID: 31165233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of proteomic research in vascular disease.
    Nordon I; Brar R; Hinchliffe R; Cockerill G; Loftus I; Thompson M
    J Vasc Surg; 2009 Jun; 49(6):1602-12. PubMed ID: 19497525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability.
    Mineharu Y; Miyamoto S
    Front Neurol; 2021; 12():687088. PubMed ID: 34381413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Operative neurosurgery: personal view and historical backgrounds (9) Moyamoya angiopathy (MMA): past history and status presens].
    Yonekawa Y
    No Shinkei Geka; 2012 Jan; 40(1):67-87. PubMed ID: 22223526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association.
    Gonzalez NR; Amin-Hanjani S; Bang OY; Coffey C; Du R; Fierstra J; Fraser JF; Kuroda S; Tietjen GE; Yaghi S;
    Stroke; 2023 Oct; 54(10):e465-e479. PubMed ID: 37609846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteome Profiling of the Dura Mater in Patients with Moyamoya Angiopathy.
    Carrozzini T; Pollaci G; Gorla G; Potenza A; Rifino N; Acerbi F; Vetrano IG; Ferroli P; Bersano A; Gianazza E; Banfi C; Gatti L
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.
    Ahel J; Lehner A; Vogel A; Schleiffer A; Meinhart A; Haselbach D; Clausen T
    Elife; 2020 Jun; 9():. PubMed ID: 32573437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moyamoya Biomarkers.
    Smith ER
    J Korean Neurosurg Soc; 2015 Jun; 57(6):415-21. PubMed ID: 26180608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.
    Miskinyte S; Butler MG; Hervé D; Sarret C; Nicolino M; Petralia JD; Bergametti F; Arnould M; Pham VN; Gore AV; Spengos K; Gazal S; Woimant F; Steinberg GK; Weinstein BM; Tournier-Lasserve E
    Am J Hum Genet; 2011 Jun; 88(6):718-728. PubMed ID: 21596366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Moyamoya disease in adults: treatment methods in modern era].
    Krylov VV; Senko IV; Amiralieva MS; Staroverov MS; Grigoryev IV; Kordonskaya OO; Glotova NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(3. Vyp. 2):75-82. PubMed ID: 38512098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiopoietin-2 associates with poor prognosis in Moyamoya angiopathy.
    Gorla G; Potenza A; Carrozzini T; Pollaci G; Acerbi F; Vetrano IG; Ferroli P; Canavero I; Rifino N; Bersano A; Gatti L
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1590-1603. PubMed ID: 38655722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene.
    Fujimura M; Sonobe S; Nishijima Y; Niizuma K; Sakata H; Kure S; Tominaga T
    J Stroke; 2014 May; 16(2):65-72. PubMed ID: 24949311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moyamoya Syndrome Secondary to Coinfection of Meningovascular Neurosyphilis and Acquired Immunodeficiency Syndrome.
    Uygun GG; Darici D; Cil MG; Bastug Z; Misirli CH
    Cureus; 2024 May; 16(5):e60579. PubMed ID: 38894803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease.
    Mikami T; Suzuki H; Komatsu K; Mikuni N
    Neurol Med Chir (Tokyo); 2019 Oct; 59(10):361-370. PubMed ID: 31281171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moyamoya Angiopathy: An Underdiagnosed Cause of Ischemic Stroke in a Tunisian Pediatric Cohort.
    Bouchaala W; Laroussi S; Mzid Y; Maaloul I; Jallouli O; Zouari S; Ben Nsir S; Mnif Z; Kammoun F; Triki C
    Pediatr Neurol; 2024 Jan; 150():3-9. PubMed ID: 37925769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative computed tomography perfusion in pediatric moyamoya disease: a single-institution experience.
    Ravindra VM; Kralik SF; Griauzde J; Gadgil N; LoPresti MA; Lam S
    J Neurosurg Pediatr; 2020 May; 25(5):484-491. PubMed ID: 31978885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative clinical symptomatology and stroke burden in pediatric moyamoya angiopathy: Defining associated risk variables.
    Hackenberg A; Battilana B; Hebeisen M; Steinfeld R; Khan N
    Eur J Paediatr Neurol; 2021 Nov; 35():130-136. PubMed ID: 34715507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.